Non-systemic chemotherapy in the treatment of colorectal cancer-portal vein, hepatic arterial and intraperitoneal approaches

This publication has 50 references indexed in Scilit:

• Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983–1987)
  European Journal of Cancer, 1997
• Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy
  Cancer, 1996
• Combined intraperitoneal plus intravenous chemotherapy after curative resection for colonic adenocarcinoma
  European Journal of Cancer, 1995
• Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update
  Cancer, 1994
• Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.
  BMJ, 1993
• A phase I study of regionally administered mitomycin microcapsules for patients with colorectal liver metastases
  European Journal of Cancer and Clinical Oncology, 1991
• Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases
  British Journal of Surgery, 1990
• Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterialversus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial
  Cancer, 1989
• A Prospective Phase II Clinical Trial of Continuous FUDR Regional Chemotherapy for Colorectal Metastases to the Liver
  Annals of Surgery, 1983
• The Prophylactic Treatment of Cancer at the Time of Operation
  Annals of Surgery, 1957